ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko00190	Oxidative phosphorylation	60/110	127/7206	1.4392138826e-81
ko05012	Parkinson's disease	60/110	155/7206	6.64312617411e-75
ko05016	Huntington's disease	59/110	215/7206	4.77048078048e-63
ko05010	Alzheimer's disease	57/110	202/7206	2.01754489687e-61
ko04932	Non-alcoholic fatty liver disease (NAFLD)	50/110	182/7206	1.91310927352e-52
ko04723	Retrograde endocannabinoid signaling	32/110	175/7206	1.29195918365e-26
ko04260	Cardiac muscle contraction	15/110	98/7206	1.37654689605e-11
ko03010	Ribosome	14/110	129/7206	7.30910480628e-09
ko01200	Carbon metabolism	13/110	128/7206	5.84348779075e-08
ko00020	Citrate cycle (TCA cycle)	7/110	35/7206	7.53700230026e-07
ko00280	Valine, leucine and isoleucine degradation	7/110	54/7206	1.56366749525e-05
ko00640	Propanoate metabolism	5/110	34/7206	0.000147931090799
ko00062	Fatty acid elongation	4/110	33/7206	0.00149555512621
ko01212	Fatty acid metabolism	5/110	60/7206	0.00212009140755
ko05200	Pathways in cancer	1/110	492/7206	0.00668342480264
ko00650	Butanoate metabolism	3/110	26/7206	0.00696972146368
ko00930	Caprolactam degradation	2/110	9/7206	0.0077511113752
ko00920	Sulfur metabolism	2/110	10/7206	0.00959284561493
ko00010	Glycolysis / Gluconeogenesis	4/110	74/7206	0.026138452347
ko02020	Two-component system	2/110	17/7206	0.027047909146
ko00071	Fatty acid degradation	3/110	45/7206	0.0308879723083
ko00620	Pyruvate metabolism	3/110	46/7206	0.0326854363162
ko01210	2-Oxocarboxylic acid metabolism	2/110	20/7206	0.0366868065347
ko00380	Tryptophan metabolism	3/110	50/7206	0.0404088774103
ko03070	Bacterial secretion system	1/110	3/7206	0.0451058259173
ko00785	Lipoic acid metabolism	1/110	3/7206	0.0451058259173
ko03060	Protein export	2/110	23/7206	0.0474336006557